rs2687834
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_003235.5(TG):c.4002+1242G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 151,932 control chromosomes in the GnomAD database, including 15,547 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 15547 hom., cov: 31)
Consequence
TG
NM_003235.5 intron
NM_003235.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0440
Publications
6 publications found
Genes affected
TG (HGNC:11764): (thyroglobulin) Thyroglobulin (Tg) is a glycoprotein homodimer produced predominantly by the thryroid gland. It acts as a substrate for the synthesis of thyroxine and triiodothyronine as well as the storage of the inactive forms of thyroid hormone and iodine. Thyroglobulin is secreted from the endoplasmic reticulum to its site of iodination, and subsequent thyroxine biosynthesis, in the follicular lumen. Mutations in this gene cause thyroid dyshormonogenesis, manifested as goiter, and are associated with moderate to severe congenital hypothyroidism. Polymorphisms in this gene are associated with susceptibility to autoimmune thyroid diseases (AITD) such as Graves disease and Hashimoto thryoiditis. [provided by RefSeq, Nov 2009]
TG Gene-Disease associations (from GenCC):
- thyroid dyshormonogenesis 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial thyroid dyshormonogenesisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.525 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.409 AC: 62078AN: 151814Hom.: 15548 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
62078
AN:
151814
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.409 AC: 62072AN: 151932Hom.: 15547 Cov.: 31 AF XY: 0.415 AC XY: 30780AN XY: 74230 show subpopulations
GnomAD4 genome
AF:
AC:
62072
AN:
151932
Hom.:
Cov.:
31
AF XY:
AC XY:
30780
AN XY:
74230
show subpopulations
African (AFR)
AF:
AC:
4429
AN:
41466
American (AMR)
AF:
AC:
8157
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1695
AN:
3468
East Asian (EAS)
AF:
AC:
1833
AN:
5144
South Asian (SAS)
AF:
AC:
2398
AN:
4816
European-Finnish (FIN)
AF:
AC:
6429
AN:
10540
Middle Eastern (MID)
AF:
AC:
145
AN:
292
European-Non Finnish (NFE)
AF:
AC:
35566
AN:
67928
Other (OTH)
AF:
AC:
913
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1570
3140
4710
6280
7850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1456
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 21
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.